Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small ubiquitin-related modifier proteins (SUMOs) are a family of small proteins structurally similar to ubiquitin. They are covalently attached to lysine residues on target proteins in a process known as SUMOylation, which is a type of post-translational modification. SUMOylation regulates various cellular processes including nuclear-cytosolic transport, transcriptional regulation, DNA repair and replication, mitosis, apoptosis, and protein stability.
Selective degradation of SUMO1; Modulation of SUMOylation pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small Ubiquitin-Related Modifier Protein (SUMO).